Clinical Trials Directory

Trials / Conditions / Advanced Malignancy

Advanced Malignancy

22 registered clinical trials studyying Advanced Malignancy — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingImmunotherapy Master Trial for Advanced Cancers
NCT07431073
UNICANCERPhase 2
RecruitingADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
NCT07238075
Adcytherix SASPhase 1
Not Yet RecruitingClinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal
NCT07209384
Junpeng WangPhase 2
RecruitingA Trial of SHR-7782 for Treatment of Advanced Malignant Tumors
NCT07123129
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1
CompletedStudy of IBI318 in Participants With Advanced Malignancies
NCT03875157
Innovent Biologics (Suzhou) Co. Ltd.Phase 1
CompletedA Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies
NCT02978482
AstraZenecaPhase 1
CompletedA Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
NCT02743637
SynDevRx, Inc.Phase 1
TerminatedSafety Study of AMG 228 to Treat Solid Tumors
NCT02437916
AmgenPhase 1
CompletedA Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
NCT02110355
Kartos Therapeutics, Inc.Phase 1
CompletedA Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
NCT02016729
Kartos Therapeutics, Inc.Phase 1
CompletedA Study of Anlotinib in Subjects With Advanced Malignancy
NCT04216082
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2
CompletedA Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
NCT01723020
Kartos Therapeutics, Inc.Phase 1
CompletedChanging the Paradigm of In-Hospital Cardiopulmonary Resuscitation
NCT01558817
University of VermontN/A
CompletedQUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
NCT01231347
NantCell, Inc.Phase 3
CompletedA Study of AMG 337 in Subjects With Advanced Solid Tumors
NCT01253707
AmgenPhase 1
No Longer AvailableXL999 Administered Intravenously to a Subject With Advanced Malignancies
NCT01945164
John Sarantopoulos—
CompletedA Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Adv
NCT00978926
National University Hospital, Singapore—
CompletedA Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
NCT00858377
AmgenPhase 1
CompletedA Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
NCT00813384
AmgenPhase 1
CompletedA Study of AMG 820 in Subjects With Advanced Solid Tumors
NCT01444404
AmMax Bio, Inc.Phase 1
CompletedBevacizumab and Bortezomib in Patients With Advanced Malignancy
NCT00428545
M.D. Anderson Cancer CenterPhase 1
CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors
NCT00974896
NantCell, Inc.Phase 1